NEW ASPECTS OF DNA RECOGNITION BY NUCLEAR RECEPTORS
核受体 DNA 识别的新方面
基本信息
- 批准号:2623459
- 负责人:
- 金额:$ 16.33万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1998
- 资助国家:美国
- 起止时间:1998-07-23 至 2002-05-31
- 项目状态:已结题
- 来源:
- 关键词:DNA binding protein RNA splicing chromosome translocation dimer genetic regulatory element high performance liquid chromatography hormone receptor nuclear membrane nucleic acid sequence phosphorylation polymerase chain reaction posttranslational modifications protein sequence protein structure receptor binding tissue /cell culture transcription factor
项目摘要
Our ultimate goal is to better understand how different nuclear
hormone receptors recognize different target DNA sequences. Nuclear
hormone receptors are ligand-regulated transcription factors, and
modulate the expression of specific target genes in response to small
hydrophobic hormones, such as steroids, thyroid hormones, and
retinoids. The DNA recognition properties of each receptor play the
critical role of defining the particular repertoire of target genes
which respond to a given hormone. However, our understanding in
incomplete of how the nuclear receptors, which posses generally
similar zinc-finger domains, manifest the specificity necessary to
recognize inherently distinct sets of target genes. Recent work by
ourselves and others has revealed that: (A) regions outside of the
zinc-finger domain play critical and unanticipated roles in DNA
sequence-specificity, (B) nuclear hormone receptors recognize DNA
binding sites not only as protein dimers, but also by novel
mechanisms involving monomers and high-order oligomeric complexes,
and ~ post-translational protein modifications can alter DNA
recognition. These observations confirm that important elements of
DNA recognition by nuclear receptors have not been previously
explored, and suggest plausible mechanisms by which the specificity
of different receptors for different target genes is generated and
defined. We will investigate:
A. How do different nuclear receptors recognize distinct DNA half-
sites?
B. What are the different roles of protein monomers, dimers and
oligomers in DNA recognition by different members of the nuclear
hormone receptor family.
C. Is the mode and specificity of DNA recognition by nuclear
receptors altered by post-translational modification, alternative
splicing, or chromosomal translocations?
Nuclear hormone receptors play central roles in metazoan homeostasis,
development, and differentiation. Aberrant human receptors have been
implicated in many endocrine and neoplastic diseases. Our
experiments will help resolve important aspects of nuclear hormone
receptor signaling and physiology, and will also contribute toward a
broader comprehension of how DNA recognition specificity is achieved
by other transcription factors.
我们的最终目标是更好地理解不同的核能
激素受体识别不同的靶DNA序列。核子
激素受体是配体调节的转录因子,并且
调节特定靶基因的表达以响应小分子
疏水激素,如类固醇、甲状腺激素和
维甲酸。每种受体的DNA识别特性都发挥了作用
确定特定的靶基因谱系的关键作用
它们对特定的荷尔蒙做出反应。然而,我们对此的理解
不完整的核受体,它通常拥有
相似的锌指结构域,表现出必要的特异性
识别天生不同的靶基因集合。最近的工作由
我们自己和其他人已经透露:(A)
锌指结构域在DNA中扮演着关键和意想不到的角色
序列特异性,(B)核激素受体识别DNA
结合位点不仅作为蛋白质二聚体,而且还通过新的
涉及单体和高阶低聚络合物的机理,
翻译后蛋白质修饰可以改变DNA
承认。这些观察结果证实了
核受体对DNA的识别以前从未出现过
探索并提出了可信的机制,通过这些机制,
产生针对不同靶基因的不同受体,并且
已定义。我们将调查:
答:不同的核受体如何识别不同的DNA
网站?
B.蛋白质单体、二聚体和蛋白质的不同作用
核内不同成员识别DNA的寡聚体
激素受体家族。
C.是核识别DNA的模式和特异性
翻译后修饰改变的受体,可选
剪接,还是染色体易位?
核激素受体在后生动物的动态平衡中起着核心作用,
发展和差异化。异常的人类受体已经被
与许多内分泌和肿瘤疾病有关。我们的
实验将有助于解决核激素的重要方面
受体信号和生理学,也将有助于
更广泛地理解DNA识别的特异性是如何实现的
通过其他转录因子。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Martin L. Privalsky其他文献
Martin L. Privalsky的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Martin L. Privalsky', 18)}}的其他基金
Role of cofactors in nuclear hormone receptor function.
辅因子在核激素受体功能中的作用。
- 批准号:
8010061 - 财政年份:2010
- 资助金额:
$ 16.33万 - 项目类别:
Role of thyroid hormone receptor mutants in hepatocellular carcinoma
甲状腺激素受体突变体在肝细胞癌中的作用
- 批准号:
7175777 - 财政年份:2006
- 资助金额:
$ 16.33万 - 项目类别:
Role of thyroid hormone receptor mutants in hepatocellular carcinoma
甲状腺激素受体突变体在肝细胞癌中的作用
- 批准号:
7392190 - 财政年份:2006
- 资助金额:
$ 16.33万 - 项目类别:
Role of cofactors in nuclear hormone receptor function.
辅因子在核激素受体功能中的作用。
- 批准号:
6896110 - 财政年份:1998
- 资助金额:
$ 16.33万 - 项目类别:
NEW ASPECTS OF DNA RECOGNITION BY NUCLEAR RECEPTORS
核受体 DNA 识别的新方面
- 批准号:
2906236 - 财政年份:1998
- 资助金额:
$ 16.33万 - 项目类别:
Role of cofactors in nuclear hormone receptor function.
辅因子在核激素受体功能中的作用。
- 批准号:
6654317 - 财政年份:1998
- 资助金额:
$ 16.33万 - 项目类别:
Role of cofactors in nuclear hormone receptor function.
辅因子在核激素受体功能中的作用。
- 批准号:
6545145 - 财政年份:1998
- 资助金额:
$ 16.33万 - 项目类别:
Role of cofactors in nuclear hormone receptor function.
辅因子在核激素受体功能中的作用。
- 批准号:
7316535 - 财政年份:1998
- 资助金额:
$ 16.33万 - 项目类别:
Role of cofactors in nuclear hormone receptor function.
辅因子在核激素受体功能中的作用。
- 批准号:
8510378 - 财政年份:1998
- 资助金额:
$ 16.33万 - 项目类别:
相似海外基金
Mechanisms of messenger RNA splicing and RNA processing regulation
信使RNA剪接和RNA加工调控机制
- 批准号:
10623834 - 财政年份:2023
- 资助金额:
$ 16.33万 - 项目类别:
Analysis on how RNA splicing factors change global gene expression patterns and regulate male fertility.
分析RNA剪接因子如何改变全局基因表达模式并调节男性生育能力。
- 批准号:
2882792 - 财政年份:2023
- 资助金额:
$ 16.33万 - 项目类别:
Studentship
Collaborative Research: Connecting the sequence logic of RNA splicing to nuclear localization
合作研究:将 RNA 剪接的序列逻辑与核定位联系起来
- 批准号:
2246530 - 财政年份:2023
- 资助金额:
$ 16.33万 - 项目类别:
Standard Grant
Collaborative Research: Connecting the sequence logic of RNA splicing to nuclear localization
合作研究:将 RNA 剪接的序列逻辑与核定位联系起来
- 批准号:
2246531 - 财政年份:2023
- 资助金额:
$ 16.33万 - 项目类别:
Standard Grant
Aberrant RNA splicing in sporadic inclusion body myositis
散发性包涵体肌炎中的异常RNA剪接
- 批准号:
23K18260 - 财政年份:2023
- 资助金额:
$ 16.33万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
Synthetic introns for selective targeting of RNA splicing factor-mutant leukemia
用于选择性靶向RNA剪接因子突变型白血病的合成内含子
- 批准号:
10722782 - 财政年份:2023
- 资助金额:
$ 16.33万 - 项目类别:
Cancer immune therapeutics targeting aberrant RNA splicing products
针对异常 RNA 剪接产物的癌症免疫疗法
- 批准号:
23H02688 - 财政年份:2023
- 资助金额:
$ 16.33万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
RNA splicing regulation during alcohol withdrawal
酒精戒断过程中的 RNA 剪接调节
- 批准号:
10785159 - 财政年份:2023
- 资助金额:
$ 16.33万 - 项目类别:
Targeting Dysregulated RNA Splicing in Neurodegenerative Diseases
靶向神经退行性疾病中失调的 RNA 剪接
- 批准号:
10729566 - 财政年份:2023
- 资助金额:
$ 16.33万 - 项目类别:
Function, composition, and mechanism of RNA splicing factories in cardiomyopathy
RNA剪接工厂在心肌病中的功能、组成和机制
- 批准号:
10583011 - 财政年份:2022
- 资助金额:
$ 16.33万 - 项目类别: